Evidence map›Paper›PMID 33968023›Full record

ReviewFrontiers in immunology2021

Tetraspanins as Potential Therapeutic Candidates for Targeting Flaviviruses.

Waqas Ahmed, Girish Neelakanta, Hameeda Sultana

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Functional analysis ofThe Journal of general virology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Extracellular Vesicles inInternational journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Tetraspanins: Host Factors in Viral Infections.International journal of molecular sciences · 2021
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Waqas AhmedDepartment of Biological Sciences, Old Dominion University, Norfolk, VA, United States.
Girish NeelakantaDepartment of Biological Sciences, Old Dominion University, Norfolk, VA, United States.
Hameeda SultanaDepartment of Biological Sciences, Old Dominion University, Norfolk, VA, United States.
Old Dominion University · US

Funding

Arthropod exosomes mediate vector-pathogen interactionsR01AI141790 · NIAID · UNIVERSITY OF TENNESSEE KNOXVILLE · PI SULTANA, HAMEEDA · 2019 to 2023
$2.1M
NIAID NIH HHS R01 AI141790
6 · The paper itself

Abstract

Tetraspanin family of proteins participates in numerous fundamental signaling pathways involved in viral transmission, virus-specific immunity, and virus-mediated vesicular trafficking. Studies in the identification of novel therapeutic candidates and strategies to target West Nile virus, dengue and Zika viruses are highly warranted due to the failure in development of vaccines. Recent evidences have shown that the widely distributed tetraspanin proteins may provide a platform for the development of novel therapeutic approaches. In this review, we discuss the diversified and important functions of tetraspanins in exosome/extracellular vesicle biology, virus-host interactions, virus-mediated vesicular trafficking, modulation of immune mechanism(s), and their possible role(s) in host antiviral defense mechanism(s) through interactions with noncoding RNAs. We also highlight the role of tetraspanins in the development of novel therapeutics to target arthropod-borne flaviviral diseases.

Indexed as

ExosomesExtracellular VesiclesFlavivirus InfectionsHost Microbial InteractionsHumansImmunomodulationRNA, UntranslatedTetraspaninsRNA, UntranslatedTetraspaninsarthropodsexosomesflavivirusesncRNAstetraspaninstransmission

Identifiers

PMID33968023
PMCPMC8097176
OpenAlexW3158530994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.